Impacts

Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease

Claude Michel Wischik (Participant), Charles Robert Harrington (Participant), John Mervyn David Storey (Participant), Janet Elizabeth Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven John Kemp (Participant), James Peter Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant), C Marshall (Participant)

Impact: Quality of life Impacts, Economic Impacts

International Standards for Portland-Limestone Cements

Fredrik Paul Glasser (Coordinator), Donald MacPhee (Coordinator)

Impact